advertisement

Topcon

Huang J 19

Showing records 1 to 19 | Display all abstracts from Huang J

73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Lin J
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma Patients
Dai M
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Huang J
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Wang Z
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma Patients
Xu J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Peng T
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma Patients
Lin J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Chung C
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Li Y
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Xu J
PLoS ONE 2017; 12: e0177769
72873 Willingness to Use Mobile Health in Glaucoma Patients
Wang Z
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Zhan Z
AAPS PharmSciTech 2017; 18: 2919-2926
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Dai M
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Zeng Y
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma Patients
Huang W
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Huang Y
AAPS PharmSciTech 2017; 18: 2919-2926
72873 Willingness to Use Mobile Health in Glaucoma Patients
Huang J
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2017; 23: 822-827
73144 Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects
Huang J
PLoS ONE 2017; 12: e0177769
72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Pan X; Wu CY; Wu C
AAPS PharmSciTech 2017; 18: 2919-2926

Issue 18-4

Change Issue


advertisement

Topcon